Cargando…

PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes

INTRODUCTION/BACKGROUND: Type 1 diabetes (T1D) is associated with decreased skeletal muscle mass (SMM) and impaired muscle function in adults. Despite the importance of skeletal muscle in insulin action and metabolic homeostasis, our understanding of skeletal muscle health in children with T1D is ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrix, Grace, Shankaran, Mahalakshmi, Ramaker, Megan, Evans, William, Hellerstein, Marc, Muehlbauer, Michael, Rasbach, Lisa, Benjamin, Robert, Freemark, Michael, Balikcioglu, Pinar Gumus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625145/
http://dx.doi.org/10.1210/jendso/bvac150.1317
_version_ 1784822414405795840
author Hendrix, Grace
Shankaran, Mahalakshmi
Ramaker, Megan
Evans, William
Hellerstein, Marc
Muehlbauer, Michael
Rasbach, Lisa
Benjamin, Robert
Freemark, Michael
Balikcioglu, Pinar Gumus
author_facet Hendrix, Grace
Shankaran, Mahalakshmi
Ramaker, Megan
Evans, William
Hellerstein, Marc
Muehlbauer, Michael
Rasbach, Lisa
Benjamin, Robert
Freemark, Michael
Balikcioglu, Pinar Gumus
author_sort Hendrix, Grace
collection PubMed
description INTRODUCTION/BACKGROUND: Type 1 diabetes (T1D) is associated with decreased skeletal muscle mass (SMM) and impaired muscle function in adults. Despite the importance of skeletal muscle in insulin action and metabolic homeostasis, our understanding of skeletal muscle health in children with T1D is very limited. Here we used a novel, non-invasive methodology to compare muscle mass (MM) in children with T1D and sex and age-matched healthy children without diabetes. OBJECTIVES: We hypothesized that: (a) children with T1D have lower MM than age, sex, and BMI-matched children without T1D; (b) MM in children with T1D correlates with insulin sensitivity and glycemic control. METHODS: Weight (BW), height, BMI%, body fat% (BF%), daily insulin requirement, CGM data, HbA1c, and total and HMW adiponectin were measured in 24 young children (15 females, 9 males; age 6-11 years) with T1D. BF% and fat-free-mass (FFM) was measured by bioelectrical impedance. Insulin sensitivity was assessed by total and HMW-adiponectin and daily insulin requirements. Glycemic control was assessed by glucose time in range, mean blood glucose, and HbA1c. MM was measured using the D(3)creatine dilution method in 22 of the children with T1D (14 females, 8 males) and, in a separate study, in 34 children without T1D (17 females and 17 males). This method involves an oral 10 mg dose of deuterated creatine (methyl-d3, D(3)Cr). Creatine is converted in vivo to creatinine, including D(3)Cr to D(3)creatinine, in muscle by an irreversible, nonenzymatic reaction and then excreted. A single fasting urine sample is collected to determine D(3)creatinine enrichment. MM/BW (%) was calculated to normalize for body weight. RESULTS: There were strong positive associations between MM and body weight (r=0.85, p<0.0001), BMI (r=0.61, p=0.0028), and FFM (r=0.72, p=0.0040). Although children with T1D were slightly older (9.2 ±1.3 vs 8.1± 1.2 yo, p=0.003) and had higher BMI (18± 2.3 vs16.0 ±2.0, p=0.001) than controls, they had lower %MM/BW than children without diabetes (37.8± 4.6 vs 43.1±4.5%, p<0.0001). The lower %MM/BW in T1D compared to controls was confirmed in sub-cohorts matched for age and in males and females analyzed separately. Mean daily insulin requirement and HbA1c in the children with T1D were 0.76±0.15 IU/kg/day and 7.1±1.1%, respectively. MM, FFM, %BF, FM, %MM/BW did not correlate with metrics of insulin sensitivity or glycemic control. CONCLUSIONS: This is the first study to quantitate MM directly in young children with T1D. Our results demonstrate a lower %MM in 6–11-year-old pre-pubertal children with T1D with stable and reasonable glycemic control. The cause for the lower % MM in T1D is not clear; however future studies could examine the rates of muscle protein and fat synthesis and breakdown in healthy and diabetic children along with their relations to insulin administration, metabolic control, growth, and pubertal development. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.
format Online
Article
Text
id pubmed-9625145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96251452022-11-14 PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes Hendrix, Grace Shankaran, Mahalakshmi Ramaker, Megan Evans, William Hellerstein, Marc Muehlbauer, Michael Rasbach, Lisa Benjamin, Robert Freemark, Michael Balikcioglu, Pinar Gumus J Endocr Soc Pediatric Endocrinology INTRODUCTION/BACKGROUND: Type 1 diabetes (T1D) is associated with decreased skeletal muscle mass (SMM) and impaired muscle function in adults. Despite the importance of skeletal muscle in insulin action and metabolic homeostasis, our understanding of skeletal muscle health in children with T1D is very limited. Here we used a novel, non-invasive methodology to compare muscle mass (MM) in children with T1D and sex and age-matched healthy children without diabetes. OBJECTIVES: We hypothesized that: (a) children with T1D have lower MM than age, sex, and BMI-matched children without T1D; (b) MM in children with T1D correlates with insulin sensitivity and glycemic control. METHODS: Weight (BW), height, BMI%, body fat% (BF%), daily insulin requirement, CGM data, HbA1c, and total and HMW adiponectin were measured in 24 young children (15 females, 9 males; age 6-11 years) with T1D. BF% and fat-free-mass (FFM) was measured by bioelectrical impedance. Insulin sensitivity was assessed by total and HMW-adiponectin and daily insulin requirements. Glycemic control was assessed by glucose time in range, mean blood glucose, and HbA1c. MM was measured using the D(3)creatine dilution method in 22 of the children with T1D (14 females, 8 males) and, in a separate study, in 34 children without T1D (17 females and 17 males). This method involves an oral 10 mg dose of deuterated creatine (methyl-d3, D(3)Cr). Creatine is converted in vivo to creatinine, including D(3)Cr to D(3)creatinine, in muscle by an irreversible, nonenzymatic reaction and then excreted. A single fasting urine sample is collected to determine D(3)creatinine enrichment. MM/BW (%) was calculated to normalize for body weight. RESULTS: There were strong positive associations between MM and body weight (r=0.85, p<0.0001), BMI (r=0.61, p=0.0028), and FFM (r=0.72, p=0.0040). Although children with T1D were slightly older (9.2 ±1.3 vs 8.1± 1.2 yo, p=0.003) and had higher BMI (18± 2.3 vs16.0 ±2.0, p=0.001) than controls, they had lower %MM/BW than children without diabetes (37.8± 4.6 vs 43.1±4.5%, p<0.0001). The lower %MM/BW in T1D compared to controls was confirmed in sub-cohorts matched for age and in males and females analyzed separately. Mean daily insulin requirement and HbA1c in the children with T1D were 0.76±0.15 IU/kg/day and 7.1±1.1%, respectively. MM, FFM, %BF, FM, %MM/BW did not correlate with metrics of insulin sensitivity or glycemic control. CONCLUSIONS: This is the first study to quantitate MM directly in young children with T1D. Our results demonstrate a lower %MM in 6–11-year-old pre-pubertal children with T1D with stable and reasonable glycemic control. The cause for the lower % MM in T1D is not clear; however future studies could examine the rates of muscle protein and fat synthesis and breakdown in healthy and diabetic children along with their relations to insulin administration, metabolic control, growth, and pubertal development. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625145/ http://dx.doi.org/10.1210/jendso/bvac150.1317 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Hendrix, Grace
Shankaran, Mahalakshmi
Ramaker, Megan
Evans, William
Hellerstein, Marc
Muehlbauer, Michael
Rasbach, Lisa
Benjamin, Robert
Freemark, Michael
Balikcioglu, Pinar Gumus
PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes
title PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes
title_full PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes
title_fullStr PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes
title_full_unstemmed PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes
title_short PSAT117 Lower Muscle Mass Relative to Body Weight in Pre-pubertal Children with Type 1 Diabetes
title_sort psat117 lower muscle mass relative to body weight in pre-pubertal children with type 1 diabetes
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625145/
http://dx.doi.org/10.1210/jendso/bvac150.1317
work_keys_str_mv AT hendrixgrace psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT shankaranmahalakshmi psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT ramakermegan psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT evanswilliam psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT hellersteinmarc psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT muehlbauermichael psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT rasbachlisa psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT benjaminrobert psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT freemarkmichael psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes
AT balikcioglupinargumus psat117lowermusclemassrelativetobodyweightinprepubertalchildrenwithtype1diabetes